Compounds useful as A3 adenosine receptor agonists
US7414036B2 · kind B2 · utility
90Cited by
7References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 26, 2004 |
| Grant date | Aug 19, 2008 |
| Priority date | — |
| Expiry date | Jul 12, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/7076
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Adenosine analogue-type A3 receptor agonists having the formulawhereinD is N or CH;E is O;X1 is a group of the formula —CR20R2 1-CYCLE, where
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.